I3LUNG: personalized medical care in patients with lung cancer

Designed and presented to implement an innovative, sustainable and high-quality healthcare methodology, I3LUNG is a research initiative in the field of lung cancer that aims to create an innovative decision-making tool that will help both doctors and their patients to select the best therapeutic choice. It will use Artificial Intelligence (AI), in particular the “Deep Learning” and “Machine Learning” methodologies, to analyze a large amount of information. The clinical characteristics, the radiological and molecular images of the tumor of 2,000 patients enrolled in clinical trials in the participating centers will be collected and “multiomic” biological data will be generated, including the mutational load of the tumor, the analysis of the intestinal microbiome, the tumor and circulating immune expression profile, and the metabolomics of 200 patients enrolled in the prospective part of the study.